NanoString Technologies (NSTG) Releases Earnings Results, Beats Expectations By $0.01 EPS
NanoString Technologies (NASDAQ:NSTG) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.56) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.57) by $0.01, Morningstar.com reports. NanoString Technologies had a negative return on equity of 201.90% and a negative net margin of 54.34%. The business had revenue of $28.62 million during the quarter, compared to analysts’ expectations of $25.90 million. NanoString Technologies updated its FY 2018 guidance to $-2.5–2.6 EPS.
NSTG opened at $15.96 on Friday. NanoString Technologies has a 12 month low of $5.87 and a 12 month high of $18.86. The firm has a market cap of $453.37 million, a P/E ratio of -8.67 and a beta of 0.73. The company has a quick ratio of 2.01, a current ratio of 2.49 and a debt-to-equity ratio of 5.77.
In related news, Director Nicholas Galakatos sold 85,823 shares of the business’s stock in a transaction on Monday, September 17th. The stock was sold at an average price of $15.99, for a total transaction of $1,372,309.77. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mary Tedd Allen sold 26,895 shares of the business’s stock in a transaction on Monday, October 1st. The stock was sold at an average price of $17.60, for a total value of $473,352.00. The disclosure for this sale can be found here. Insiders own 20.90% of the company’s stock.
A number of equities research analysts have recently weighed in on NSTG shares. Morgan Stanley lifted their price objective on NanoString Technologies from $12.00 to $16.00 and gave the company an “equal weight” rating in a research note on Friday, July 13th. ValuEngine cut NanoString Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, July 19th. Zacks Investment Research raised NanoString Technologies from a “hold” rating to a “buy” rating and set a $14.00 price objective for the company in a research note on Tuesday, August 7th. Robert W. Baird lifted their price objective on NanoString Technologies from $15.00 to $18.00 and gave the company an “outperform” rating in a research note on Tuesday, September 11th. Finally, JPMorgan Chase & Co. lifted their price objective on NanoString Technologies to $20.00 and gave the company an “overweight” rating in a research note on Thursday, September 13th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $19.60.
ILLEGAL ACTIVITY WARNING: This news story was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2018/11/10/nanostring-technologies-nstg-releases-earnings-results-beats-expectations-by-0-01-eps.html.
About NanoString Technologies
NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.
Read More: Market Capitalization
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.